Corporate Board Profile
Tech Score: 20/100
1 mention(s) identify MICHAEL J. COYLE as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| HAEMONETICS CORP | 2024-06-07 | Former President and Chief Executive Officer, iRhythm Technologies, Inc. | Experience in digital healthcare and holds patents related to cardiovascular medical devices. |
| Filing Date | Source Excerpt |
|---|---|
| 2020-06-08 | Michael J. Coyle Executive Vice President and Group President, Cardiac and Vascular Group, Medtronic plc Age: 58 Mr. Coyle joined our Board in April 2020 and is a member of both the Audit Committee and the Governance and Compliance Committee (Mr. Coyle's committee service begins in July 2020). Since December 2009, Mr. Coyle has served as Executive Vice President and Group President, Cardiac and Vascular Group of Medtronic plc (and its predecessor, Medtronic, Inc.), a global medical device company, where he oversees four of the company’s business divisions, providing strategic direction and ensuring the alignment of integrated growth plans and cross-functional synergies. Mr. Coyle previously served as President of the Cardiac Rhythm Management division at St. Jude Medical Inc. from 2001 to 2007 and earlier in his career held numerous leadership positions at St. Jude and Eli Lilly & Company. Mr. Coyle has previously served on the boards of two NASDAQ-listed medical device companies responsible for making catheter-based products and holds six U.S. patents related to cardiovascular medical device products and technologies. |
| 2021-06-17 | Mr. Coyle joined our Board in April 2020 and is a member of both the Audit Committee and the Governance and Compliance Committee. Mr. Coyle previously served as the President and Chief Executive Officer of iRhythm Technologies, Inc., a digital healthcare company, from January 2021 to June 2021. From December 2009 to January 2021, Mr. Coyle served as Executive Vice President and Group President, Cardiac and Vascular Group of Medtronic plc (and its predecessor, Medtronic, Inc.), a global medical device company, where he oversaw four of the company’s business divisions. Mr. Coyle previously served as President of the Cardiac Rhythm Management division at St. Jude Medical Inc. from 2001 to 2007 and earlier in his career held numerous leadership positions at St. Jude and Eli Lilly & Company. Mr. Coyle previously served on the boards of iRhythm Technologies, Inc. and of two NASDAQ-listed medical device companies responsible for making catheter-based products. He holds six U.S. patents related to cardiovascular medical device products and technologies. |
| 2022-06-17 | Michael J. Coyle Former President and Chief Executive Officer, iRhythm Technologies, Inc. Age: 60 Mr. Coyle joined our Board in April 2020 and is a member of both the Audit Committee and the Governance and Compliance Committee. Mr. Coyle previously served as the President and Chief Executive Officer of iRhythm Technologies, Inc., a digital healthcare company, from January 2021 to June 2021. From December 2009 to January 2021, Mr. Coyle served as Executive Vice President and Group President, Cardiac and Vascular Group of Medtronic plc (and its predecessor, Medtronic, Inc.), a global medical device company, where he oversaw four of the company’s business divisions. Mr. Coyle previously served as President of the Cardiac Rhythm Management division at St. Jude Medical Inc. from 2001 to 2007 and earlier in his career held numerous leadership positions at St. Jude and Eli Lilly & Company. Mr. Coyle previously served on the boards of iRhythm Technologies, Inc. and of two NASDAQ-listed medical device companies responsible for making catheter-based products. He holds six U.S. patents related to cardiovascular medical device products and technologies. |
| 2023-06-16 | Michael J. Coyle Former President and Chief Executive Officer, iRhythm Technologies, Inc. Age: 61 Mr. Coyle joined our Board in April 2020 and is a member of both the Audit Committee and the Technology Committee. Director Compensation Table for Fiscal Year Ended April 1, 2023 Michael J. Coyle Fees Earned or Paid in Cash: $83,000 Stock Awards: $189,953 Total: $272,953 |
| 2024-06-07 | Former President and Chief Executive Officer, iRhythm Technologies, Inc. |
Data sourced from SEC filings. Last updated: 2025-08-30